Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kathryn Gregory Insider Profile
4 Followers
Kathryn Gregory, SVP, Chief Business Officer at Aileron Therapeutics, holds 84.76K shares in Carmell Therapeutics (Ticker: CTCX), holds 45.00K shares in Aileron Therapeutics (Ticker: ALRN). Most recently, Kathryn Gregory Bought ― shares of Carmell Therapeutics on Sep 10, 2024 for an estimated value of 642.60.
Kathryn Gregory Aileron Therapeutics (ALRN)SVP, Chief Business Officer
Aileron Therapeutics (ALRN)
SVP, Chief Business Officer
Ranked #91,585 out of 98,911 Corporate Insiders
Profitable Transactions
1 out of 10 Profitable Transactions
Average Return
-30.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kathryn Gregory holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 15, 2019 - Aug 15, 2020
Return:+142.60%
The most profitable trade made by Kathryn Gregory
Kathryn Gregory's Trading History
Aileron Therapeutics
Aug 15, 2019
SVP, Chief Business Officer
Informative Buy
28.80K
$144.45K
Carmell Therapeutics
Sep 10, 2024
Director
Informative Buy
642.60
$26.27K
List of latest transactions for each holding click on a transaction to see Kathryn Gregory's performance on stock
You May Also Like
Kathryn Gregory insider profile FAQ
What is the percentage of profitable transactions made by Kathryn Gregory?
The percentage of profitable transactions made by Kathryn Gregory is 10%.
What is the average return per transaction made by Kathryn Gregory?
The average return per transaction made by Kathryn Gregory is -30.50%.
What stocks does Kathryn Gregory hold?
Kathryn Gregory holds: ALRN, CTCX stocks.
What was Kathryn Gregory’s latest transaction?
Kathryn Gregory latest transaction was an Informative Buy of $642.60.
What was Kathryn Gregory's most profitable transaction?
Kathryn Gregory’s most profitable transaction was an Informative Buy of ALRN stock on August 15, 2019. The return on the trade was 142.60%.
What is Kathryn Gregory's role in Aileron Therapeutics?
Kathryn Gregory's role in Aileron Therapeutics is SVP, Chief Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.